NCT02767063
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02767063
Title Therapies in Combination or Sequentially With Tyrosine Kinase Inhibitors (TKIs) in Chronic Phase Chronic Myelogenous Leukemia Patients in CCR (ACTIW) (ACTIW)
Acronym ACTIW
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors Versailles Hospital
Indications
Therapies
Age Groups: senior | adult
Covered Countries FRA

Facility Status City State Zip Country Details
Martine GARDEMBAS Angers France Details
Pascale CONY.MAKHOUL Annecy France Details
Thorsten BRAUN Bobigny France Details
Etienne Bordeaux France Details
CHU Côte de Nacre Caen France Details
CHU Estaing Clermont-Ferrand France Details
CH Henri Mondor Créteil France Details
Rousselot Le Chesnay France Details
CHU Lille Lille France Details
CHU de LIMOGES Limoges France Details
Franck NICOLINI Lyon France Details
Institut P Calmette Marseille France Details
Viviane DUBRUILLE Nantes France Details
Hopital l'Archet Nice France Details
Eric JOURDAN Nîmes France Details
Hôpital La Source Orléans France Details
Delphine REA _St louis Paris France Details
Simona LAPUSAN_St Antoine Paris France Details
Cayssials Poitiers France Details
CHU de Rennes - Pontchaillou Rennes France Details
Hôpital René Huguenin Saint-Cloud France Details
Institut Universitaire contre le Cancer Toulouse France Details
CHU Tours Tours France Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field